What a journey you've been on — and what a positive attitude to bring to it. Your situation does sound quite unique. Having follicular lymphoma localized to a single spinal tumor with no nodal spread is indeed rare, and being restaged to stage 2 after treatment is actually an encouraging sign.
For stage 2 follicular Show Full Answer
What a journey you've been on — and what a positive attitude to bring to it. Your situation does sound quite unique. Having follicular lymphoma localized to a single spinal tumor with no nodal spread is indeed rare, and being restaged to stage 2 after treatment is actually an encouraging sign.
For stage 2 follicular lymphoma, the goal of first-line treatment like R-CHOP combined with radiotherapy is to eliminate the cancer entirely. Studies have shown that many people with early-stage follicular lymphoma treated with radiation have good outcomes, with a significant number remaining disease-free after five years. Regarding the ongoing back pain — it's very reasonable to hope that it's residual damage from the tumor rather than active disease. Tumors pressing on spinal structures can cause lasting inflammation and tissue damage that takes time to heal, even after successful treatment.
Long-term, here's what to generally expect with follicular lymphoma after treatment:
- Monitoring scans are standard practice to watch for any signs of relapse
- Remission periods can be long, especially in people who are fit and responded well to treatment
- Relapse is possible but many effective second-line treatments exist if needed
- Being younger and fit (54 and active) works strongly in your favor for tolerating any future treatment if required
The fact that your lymphoma was localized and responded to treatment is genuinely encouraging. Moving to a monitoring phase is a realistic and common next step for people in your situation.
Continuing to communicate openly with your oncology team about the back pain is important — they can help determine whether it's healing-related or needs further investigation.
May 25
Join
Your Privacy Choices
